← Evidence map

ReviewOncoTargets and therapy2016

Immune checkpoint inhibitors: the new frontier in non-small-cell lung cancer treatment.

Hazem El-Osta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

16 papers cite it

2016
2017
2018
2019
2020
2021
2022
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 27574451